To Identify KRAS Gene and Safe Margin in Association With Outcome in Colorectal Liver Metastases Following Ultrasound-guided Radiofrequency Ablation
To investigate the clinical effect of radiofrequency ablation on colorectal cancer liver metastases with different KRAS gene status
KRAS Gene|Colorectal Cancer|Liver Metastasis|Safe Margin|Radiofrequency Ablation
PROCEDURE: Radiofrequency ablation
local tumor progression, the appearance of tumor foci at the edge of the ablation zones after at least one contrast-enhanced follow-up study has documented adequate ablation and covered by the ablation zone in the target tumor and surrounding ablation margin using imaging criteria, 2020-06-01-2023-05-31
To investigate the clinical effect of radiofrequency ablation on colorectal cancer liver metastases with different KRAS gene status